Effects of caffeine on anxiety and panic attacks in patients with panic disorder: A systematic review and meta-analysis
- PMID: 34871964
- DOI: 10.1016/j.genhosppsych.2021.11.005
Effects of caffeine on anxiety and panic attacks in patients with panic disorder: A systematic review and meta-analysis
Abstract
Background: Caffeine has been purported to have anxiogenic and panicogenic properties, specifically salient in patients with panic disorder (PD). However, compilations of the magnitude of the effect of caffeine on anxiety and panic attacks are lacking and potential dose-response relationships have not been examined.
Objectives: In the present systematic review and meta-analysis, we aimed to examine the acute effects of placebo-controlled caffeine challenge on occurrence of panic attacks and subjective anxiety in patients with PD and healthy controls (HC), including dose-response relationships.
Methods: Systematic searches were performed in six databases. We included blinded placebo-controlled studies of acute caffeine challenge on panic attacks and/or subjective anxiety in adult patients with PD.
Results: Of the 1893 identified articles, ten met our inclusion criteria. The 9 studies investigating panic attacks included 237 patients, of which 51.1% had a panic attack following caffeine, but none after placebo. Six of these studies compared 128 patients with 115 healthy controls (HC), finding that patients (53.9%) were more vulnerable than HC (1.7%) for panic attacks following caffeine (log RR: 3.47; 95% CI 2.06-4.87). Six studies investigated subjective anxiety in 121 patients and 111 HC following caffeine, with an overall effect indicating increased sensitivity to the anxiogenic effects of caffeine in the patient group (Hedges' g = 1.02 [95% CI: 0.09-1.96]). The restricted range of caffeine employed [400-750 mg] and few studies (3) not using 480 mg prevented any meaningful analysis of a dose-response relationship.
Limitations: Of the ten studies included, only 2 reported anxiety data for the placebo condition, precluding a proper meta-analysis comparing anxiogenic effects of caffeine and placebo. The restricted dose range used prevented assessment of dose-response relationships.
Conclusions: The results confirm that caffeine at doses roughly equivalent to 5 cups of coffee induces panic attacks in a large proportion of PD patients and highly discriminates this population from healthy adults. Caffeine also increases anxiety in PD patients as well as among healthy adults at these doses although the exact relationship between caffeine-induced anxiety and panic attacks remains uncertain. The results suggest that caffeine targets important mechanisms related to the pathophysiology of PD.
Implications: Future studies should employ a wider range of caffeine doses and investigate contributions of biological and psychological mechanisms underlying the anxiogenic and panicogenic effects of caffeine. In the clinic, patients with PD should be informed about the panicogenic and anxiogenic effects of caffeine, with the caveat that little is known regarding smaller doses than 480 mg. Registration. PROSPERO (www.crd.york.ac.uk/prospero) registration number CRD42019120220.
Keywords: Anxiety; Caffeine challenge; Meta-analysis; Panic attack; Panic disorder; Provocation.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.Psychiatry Res. 2015 Sep 30;229(1-2):75-81. doi: 10.1016/j.psychres.2015.07.069. Epub 2015 Jul 28. Psychiatry Res. 2015. PMID: 26243374 Clinical Trial.
-
Caffeine challenge test and panic disorder: a systematic literature review.Expert Rev Neurother. 2011 Aug;11(8):1185-95. doi: 10.1586/ern.11.83. Expert Rev Neurother. 2011. PMID: 21797659 Review.
-
Caffeine challenge and breath-holding duration in patients with panic disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):41-4. doi: 10.1016/j.pnpbp.2008.10.002. Epub 2008 Oct 9. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 18930777
-
Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not.Depress Anxiety. 2008;25(9):E72-9. doi: 10.1002/da.20333. Depress Anxiety. 2008. PMID: 17427182
-
Are Internet- and mobile-based interventions effective in adults with diagnosed panic disorder and/or agoraphobia? A systematic review and meta-analysis.J Affect Disord. 2020 Nov 1;276:169-182. doi: 10.1016/j.jad.2020.06.059. Epub 2020 Jul 15. J Affect Disord. 2020. PMID: 32697696 Review.
Cited by
-
The Impact of Stress and Social Determinants on Diet in Cardiovascular Prevention in Young Women.Nutrients. 2024 Apr 3;16(7):1044. doi: 10.3390/nu16071044. Nutrients. 2024. PMID: 38613078 Free PMC article. Review.
-
Effects of Various Caffeine Doses on Cognitive Abilities in Female Athletes with Low Caffeine Consumption.Brain Sci. 2024 Mar 15;14(3):280. doi: 10.3390/brainsci14030280. Brain Sci. 2024. PMID: 38539668 Free PMC article.
-
Prevalence and Predictive Factors of Panic Disorder among Adults in Saudi Arabia: A Cross-Sectional Study.J Epidemiol Glob Health. 2024 Feb 19. doi: 10.1007/s44197-024-00208-6. Online ahead of print. J Epidemiol Glob Health. 2024. PMID: 38372895
-
Caffeine intake and anxiety: a meta-analysis.Front Psychol. 2024 Feb 1;15:1270246. doi: 10.3389/fpsyg.2024.1270246. eCollection 2024. Front Psychol. 2024. PMID: 38362247 Free PMC article.
-
Soft Drinks and Symptoms of Depression and Anxiety in Overweight Subjects: A Longitudinal Analysis of an European Cohort.Nutrients. 2023 Sep 5;15(18):3865. doi: 10.3390/nu15183865. Nutrients. 2023. PMID: 37764652 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous